HIT on Hypoglycemic Risk in Type 1 Diabetes (T1D)
Can High Intensity Interval Training Reduce Fear of Hypoglycaemia and Improve Glycaemic Control in People With Type 1 Diabetes?
1 other identifier
interventional
11
1 country
1
Brief Summary
There is clear evidence that regular exercise improves wellbeing and reduces the risk of diabetes related complications in people with type 1 diabetes. However, many people with type 1 diabetes do not exercise regularly. The primary reason for this is fear of hypoglycaemia and loss of glycaemic control associated with exercise. This loss of glycaemic control is associated with traditional moderate intensity continous aerobic exercise advocated in the guidelines for exercise in people with type 1 diabetes. Recent work (unpublished) from our lab suggests high intensity interval training (HIT) may reduce the risk of hypoglycaemia in people with type 1 diabetes, however stronger evidence is needed before firm conclusions can be drawn. Therefore, the aim of this study is to determine the effects of HIT on glycaemic control in people with type 1 diabetes compared to no exercise and traditional moderate intensity continous exercise. 24 people with type 1 diabetes will be recruited to complete a randomised counterbalanced cross over study comparing 3x 2-week interventions periods. During these intervention periods participant will maintain their habitual lifestyle but complete either no exercise (control), traditional moderate intensity continous exercise or high intensity interval training. Throughout the intervention periods participants glycaemic control will be monitored using a flash glucose monitor.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 16, 2018
CompletedFirst Posted
Study publicly available on registry
July 26, 2018
CompletedStudy Start
First participant enrolled
August 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2020
CompletedFebruary 23, 2021
February 1, 2020
2 years
July 16, 2018
February 22, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Severe hypoglycaemia
Number of severe hypoglycaemic events (\<3mmol/l) during the 2 week intervention period
2 weeks
Secondary Outcomes (8)
Mean glucose
2 weeks
% of time in level 2 hypoglycaemia (<3.0mmol/L)
2 weeks
% of time in level 1 hypoglycaemia (3.0-3.9mmol/L)
2 weeks
% of time in target range (3.9-10.0mmol/L)
2 weeks
% of time in level 1 hyperglycaemia (10.0-13.9mmol/L)
2 weeks
- +3 more secondary outcomes
Study Arms (3)
Control
NO INTERVENTIONParticipants will continue with their habitual lifestyle but perform no exercise for 2 weeks
Moderate intensity continous training
ACTIVE COMPARATORParticipants will complete moderate intensity continous training during a 2 week intervention period
high intensity interval training
EXPERIMENTALParticipants will complete high intensity interval training during a 2 week intervention period
Interventions
Participants will complete 6 sessions of high intensity interval training during a 2 week intervention period. The programme involves repeated 1 minute bouts of simple on the spot movements interspersed with 1 minute of rest.
Participants will complete 6 sessions of moderate intensity continous training during a 2 week intervention period. Participants will be asked to complete 30 minutes of continuous exercise.
Eligibility Criteria
You may qualify if:
- T1D diagnosis more than 6 months ago (to ensure participants are out of the honeymoon period),
- Using a basal bolus insulin regime or insulin pump therapy
- BMI ≤ 32 kg.m-2
You may not qualify if:
- Pregnancy (or planning pregnancy)
- Disability preventing participation in an exercise regime
- Angina
- Autonomic neuropathy
- Medication that affects heart rate (this will affect estimation of fitness)
- Major surgery planned within 6 weeks of study
- Uncontrolled blood pressure
- Significant history of hyperglycaemia
- History of severe hypoglycaemia requiring third party assistance within the last 3 months
- Severe non-proliferative and unstable proliferative retinopathy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Liverpool John Moores Universitylead
- Society for Endocrinologycollaborator
- Royal Liverpool University Hospitalcollaborator
- University of Birminghamcollaborator
- University of Exetercollaborator
Study Sites (1)
Liverpool John Moores University
Liverpool, L33AF, United Kingdom
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 16, 2018
First Posted
July 26, 2018
Study Start
August 1, 2018
Primary Completion
August 1, 2020
Study Completion
August 1, 2020
Last Updated
February 23, 2021
Record last verified: 2020-02
Data Sharing
- IPD Sharing
- Will not share
No individual participant data will be shared outside the research team. Anonymised group data will be presented in research articles and presentations